Cardlytics Inc
NASDAQ:CDLX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.96
20.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cardlytics Inc
Wall Street
Price Targets
CDLX Price Targets Summary
Cardlytics Inc
According to Wall Street analysts, the average 1-year price target for
CDLX
is 4.49 USD
with a low forecast of 4.04 USD and a high forecast of 5.25 USD.
CDLX Last Price Targets
Cardlytics Inc
The latest public price target was made on Oct 11, 2024 by
Mark Mahaney
from
Evercore ISI
,
who expects
CDLX
stock to
rise by 8%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Mark Mahaney
Evercore ISI
|
4
USD
Upside 8% |
2 months ago
Oct 11, 2024
|
Cardlytics initiated with an In Line at Evercore ISI
TheFly
|
Luke Horton
Northland Securities
|
5
USD
Upside 35% |
4 months ago
Aug 16, 2024
|
Cardlytics downgraded to Market Perform from Outperform at Northland
TheFly
|
Omar Dessouky
Bank of America Securities
|
3.5
USD
Downside 6% |
4 months ago
Aug 15, 2024
|
Cardlytics downgraded to Underperform from Neutral at BofA
TheFly
|
|
Jason Kreyer
Craig-Hallum
|
4
USD
Upside 8% |
4 months ago
Aug 8, 2024
|
Craig-Hallum downgrades Cardlytics to Hold following CEO news, Q3 guide
TheFly
|
|
Luke Horton
Northland Securities
|
7
USD
Upside 89% |
4 months ago
Aug 8, 2024
|
Cardlytics price target lowered to $7 from $14 at Northland
TheFly
|
|
Luke Horton
Northland Securities
|
14
USD
Upside 277% |
6 months ago
Jun 18, 2024
|
Northland Starts Cardlytics (CDLX) at Outperform
StreetInsider
|
Kyle Peterson
Needham
|
17
USD
Upside 358% |
8 months ago
Apr 9, 2024
|
Cardlytics (CDLX) PT Raised to $17 at Needham
StreetInsider
|
|
Kyle Peterson
Needham
|
19
USD
Upside 412% |
1 year ago
Aug 2, 2023
|
Cardlytics' Relationships With Top US Banks Is Key To Targeted Marketing Success: Analyst
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CDLX's stock price target?
Price Target
4.49
USD
According to Wall Street analysts, the average 1-year price target for
CDLX
is 4.49 USD
with a low forecast of 4.04 USD and a high forecast of 5.25 USD.
What is Cardlytics Inc's Revenue forecast?
Projected CAGR
2%
For the last 7 years the
compound annual growth rate for
Cardlytics Inc's revenue is
15%.
The projected
CAGR
for the next 4 years is
2%.
You don't have any saved screeners yet
